ebook Munafa Stock Market Course + Intraday & FNO calls  

       

PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

What is premium price of PPLPHARMA 150 CE CALL today?
Premium of PPLPHARMA 150 CE is 4.33 on 18 Mar 2026 CALL opened at 4.32 and traded inside a Low-High range of 4.20-4.45 today. Please click here table for more current prices.
What is open interest of PPLPHARMA 150 CALL CE today?
Open Interest of PPLPHARMA 150 CE is 123375 today. This has changed 26250.00 from previous day.
What is underlying price of PPLPHARMA 150 CE CALL today?
Underlying price of PPLPHARMA 150 CE CALL is 143.10 today.
What is lot size of PPLPHARMA 150 CALL CE today?
Lot size of PPLPHARMA 150 CALL CE is 2625.00
Is PPLPHARMA 150 CE CALL ITM or OTM or ATM?
PPLPHARMA 150 CALL CE is OTM CALL option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Live Options price premium & chart analysis for PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

Piramal Pharma Limited PPLPHARMA trades in NSE under NSE

Underlying equity prev closing: 143.12

PPLPHARMA CALL CE available options strikes

PPLPHARMA CE 140 strike, PPLPHARMA CE 145 strike, PPLPHARMA CE 150 strike, All CE , All PE

PPLPHARMA 150 CALL CE available expiry dates

PPLPHARMA 30 Mar 2026 expiryPPLPHARMA 28 Apr 2026 expiry

PPLPHARMA 150 CE Live prices

Premium of CALL (CE) of strike 150 is at: 4.33 on 18 Mar 2026
CALL opened at 4.32 and traded inside a Low-High range of 4.20-4.45 as on 18 Wed Mar 2026

The underlying equity is trading at 143.12 which means that CALL of strike 150 is OTM CALL option (out of the money)

Lot size of PPLPHARMA Piramal Pharma Limited is 2625

Total Open Interest for CALL (CE) of strike 150 is 123,375

Munafa analysis PPLPHARMA 150 CE might prove profitable for buyers, but sellers of this CALL could lose money trading this option

Price action analysis of 150 CALL based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of 150 CALL based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Click here to view most profitable CE and PE for Piramal Pharma Limited, both for buyers and sellers | PPLPHARMA Most Active Call Put Options

Date Underlying price CE price CE open CE high CE low CE volume CE OI OI Change
18 Wed Mar 143.12 4.33 4.32 4.45 4.20 23 323,859,375 27%
17 Tue Mar 139.05 3.50 3.61 3.62 3.19 14 254,953,125 68.2%
16 Mon Mar 138.72 3.05 3.24 3.48 2.91 -23 151,593,750 10%
13 Fri Mar 139.81 4.00 6.00 6.00 4.00 -35 137,812,500 5.3%
12 Thu Mar 145.54 6.23 6.52 7.00 6.05 -37 130,921,875 46.2%
11 Wed Mar 155.42 10.00 0.00 0.00 0.00 0 89,578,125 0%

Charts for PPLPHARMA 150 CALL CE options for Piramal Pharma Limited

Select an expiry and a strike price below to view charts for those options. PPLPHARMA All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

PPLPHARMA further analysis

PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

These are PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited . Click the links below to switch between charts

 

Videos related to: PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Using Candle Stick Charts Analysis

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

PPLPHARMA 150 CE (CALL) 28 April 2026 options price chart analysis Piramal Pharma Limited

 

Back to top